Thorne Research (THRN) Year-over-year earnings per share growth for the last twelve months

Thorne Research - graphic logo of issuer THRN

Thorne HealthTech relies on an autonomous development cycle, establishing the company as a stable defensive asset regardless of macroeconomic conditions. AI platforms and contracts with US leagues in the digital health segment provide a competitive advantage, while high product purity ensures athlete loyalty. The recorded quarterly EPS dynamics illustrate the depth of the drawdowns, where the value of 0.00 serves as the current metric.

thorne.com (THRN) Year-over-year earnings per share growth for the last 12 months: for the period 07/04/2022 - 10/21/2023

Thorne Research (THRN) - metric breakdowns and financial figures

- market value and analyst target forecast:
Price Chart Thorne HealthTech, Inc.|THRN - Average Forecast Price
- market capitalization details:
Market Value Thorne|THRN - Value Adjusted for Debt and Cash
- book capitalization data:
Net Assets per Single Share Thorne HealthTech|THRN - Accounting Capitalization|Market Capitalization to Book Value Ratio thorne.com|THRN - Company Assets
- business debt structure and liquidity details:
Total Debt to Equity Ratio Thorne HealthTech|THRN - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Thorne HealthTech|THRN - Aggregate Debt Obligations|Debts to Book Capitalization Thorne|THRN - Long-Term Debt|Company Short-Term Debts Thorne HealthTech|Quick Liquidity thorne.com
- earnings and market multiples details:
THRN - Company Net Income|Future Profit Thorne HealthTech|THRN - Market Price to Net Income Ratio|Forward P/E Multiple Thorne|THRN - Growth-Adjusted Payback Ratio|Enterprise Value to EBITDA Ratio Thorne|THRN - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) Thorne HealthTech|THRN - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth thorne.com|THRN - Net earnings per share growth this year|Earnings growth forecast for next year Thorne HealthTech
Summary company analytics:Thorne HealthTech, Inc. - THRN
Finished products of Thorne Research

The monetization of the personalized nutraceuticals digital ecosystem of Thorne HealthTech (THRN) through subscriptions and AI testing translates directly into shareholder value. The current quarterly EPS growth rate of 0.00 measures the efficiency of converting macroeconomic recovery into net income per share, allowing investors to distinguish sustainable business growth from temporary peaks prior to a market cooling phase.

Analysis of competing companies

Hims & Hers (HIMS) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Hinge Health, Inc. (HNGE)|Year-over-year earnings per share growth for the last twelve months Teladoc Inc.|TALK: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months LifeMD, Inc. (LFMD)|amwell.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth MGRX (Mangoceuticals)|DarioHealth Corp (DRIO) - Earnings per share growth in annualized terms for the last twelve months|VSEE: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months MNDR (Mobile-health Corp)|ACCD: Quarterly EPS earnings growth|biotricity.com - Year-over-year earnings per one share growth for the last 12 months|LYT (Lytus Technologies Holdings) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Ontrak Inc OTRK|Quarterly EPS earnings growth SHLT